• Aragen Bioscience, UTS Enter MoU contractpharma
    March 11, 2020
    Aragen Bioscience, a fully owned subsidiary of GVK BIO and a large molecule CRO, and University of Technology Sydney (UTS), a university in Australia, have formed a collaboration to accelerate biologics R&D in Australia.
  • GVK BIO announces new appointment biospectrumasia
    September 06, 2019
  • GVK BIO launches eCule expressbpd
    October 26, 2017
PharmaSources Customer Service